BEUDAMED
    FDA Adverse Event Injury Summary report: N

    OBTRYX SYSTEM - HALO

    MDR report key: 16961305 · Received May 19, 2023

    Report

    Report Number
    3005099803-2023-02659
    Event Type
    Injury
    Date Received
    May 19, 2023
    Date of Event
    March 20, 2018
    Report Date
    May 19, 2023
    Manufacturer
    BOSTON SCIENTIFIC CORPORATION
    Product Code
    OTN
    UDI-DI
    08714729718987
    PMA / PMN Number
    K040787
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    TX, US
    Reporter Occupation
    OTHER

    Narratives

    Additional Manufacturer Narrative · 0

    THIS EVENT WAS REPORTED BY THE PATIENT'S LEGAL REPRESENTATION. THE IMPLANT AND REVISION SURGERY SURGEON IS: (B)(6). IMDRF PATIENT CODES E2006, E2330, E1405, E1301, E2311, E1715, E0506, E232401, E2401, E0123, E1605, E1906, E0206, E0122 AND E0127 CAPTURE THE REPORTABLE EVENTS OF MESH EROSION; PAIN; DYSPAREUNIA; DYSURIA; DISCOMFORT; SCARRING; ARTERIOLAR BLEED AND HEMOPERITONEUM REQUIRING EVACUATION OF A HEMATOMA; LOSS OF RECTAL CONTROL; IMPAIRMENTS INCLUDING DIFFICULTY WALKING, SPONTANEOUS ORGASM AND OTHER COMPLICATIONS AND SYMPTOMS; OBTURATOR AND PUDENDAL NEURALGIA AND NERVED INJURY; SPASTIC PELVIC FLOOR SYNDROME; INFECTION; MENTAL INJURIES AND NUMBNESS AROUND CLITORIS AND ANUS IMDRF IMPACT CODES F1204, F1905, F1901, F2301 AND F1202 CAPTURE THE REPORTABLE EVENTS OF SURGICAL REVISION WITHOUT COMPLETE REMOVAL OF SLING; ANOTHER OBTRYX IMPLANT; CAUTERY OF AN ARTERIOLAR BLEED; PERMANENT INJURY; AND DISABILITY.

    Description of Event or Problem · 0

    NOTE: THIS MANUFACTURER REPORT PERTAINS TO THE FIRST OF THE TWO DEVICES USED DURING DIFFERENT PROCEDURES. REFER TO MANUFACTURER REPORT NUMBER 3005099803-2023-02660 FOR THE SECOND OBTRYX SYSTEM - HALO DEVICE. IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN OBTRYX SYSTEM - HALO DEVICE WAS IMPLANTED INTO THE PATIENT DURING LAPAROSCOPIC-ASSISTED VAGINAL HYSTERECTOMY WITH BILATERAL SALPINGECTOMIES + ANTERIOR AND POSTERIOR COLPORRHAPHIES PROCEDURE PERFORMED ON (B)(6) 2018 FOR PELVIC RELAXATION AND STRESS INCONTINENCE. ON (B)(6) 2018, THE DAY AFTER THE INITIAL IMPLANT, THE PLAINTIFF SUFFERED COMPLICATIONS OF HEMOPERITONEUM REQUIRING EVACUATION OF A HEMATOMA AND CAUTERY OF AN ARTERIOLAR BLEED. SHE EXPERIENCED INJURY SPECIFICALLY IMPLANTATION OF OBTRYX TRANS-OBTURATOR MID-URETHRAL SLING AND RECEIVED MEDICAL CARE INCLUDING IMPLANTATION AND SURGICAL REVISION. THE PLAINTIFF HAD EXPERIENCED SIGNIFICANT MEDICAL AND PHYSICAL PAIN AND SUFFERING, PERMANENT INJURY, HAD UNDERGONE MEDICAL TREATMENT AND WILL LIKELY UNDERGO FURTHER MEDICAL TREATMENT AND PROCEDURES. HAD SUFFERED AND WILL CONTINUE TO SUFFER SERIOUS BODILY INJURIES, INCLUDING PAIN, DISCOMFORT, PRESSURE, DIFFICULTY VOIDING URINE, CONTINUED INCONTINENCE, DISCHARGE, SCARRING, INFECTION, ODOR, BLEEDING, CHRONIC PAIN FROM NERVE INJURY, SERIOUS PHYSICAL AND MENTAL INJURIES, DISABILITY, AND OTHER LOSSES. ON MAY 3, 2021, FOLLOWING REPORTS OF FEELING A BULGE, MESH EXPOSURE, AND COMPLAINTS OF DYSPAREUNIA, THE PLAINTIFF UNDERWENT REVISION SURGERY OF ANTERIOR AND POSTERIOR COLPORRHAPHY, BILATERAL SACROSPINOUS FIXATION, AND INCOMPLETE REMOVAL OF THE SLING AND THE IMPLANTATION OF ANOTHER OBTRYX SYSTEM - HALO DEVICE. ON (B)(6) 2022, THE PLAINTIFF PRESENTED WITH RIGHT GROIN PAIN, LEFT GROIN PAIN, SPONTANEOUS ORGASM, NUMBNESS SENSATION AROUND HER CLITORIS AND ANUS. EXAMINATION NOTED INCREDIBLY SIGNIFICANT TENDERNESS AND SPASM OF THE PELVIC FLOOR MUSCLES BILATERALLY WITH EXTREME TENDERNESS WITH PALPATING MEDIAL TO THE LEFT ISCHIAL SPINE IN THE AREA CORRESPONDING WITH THE LEFT PUDENDAL NERVE AND HYPERSENSITIVITY TO TOUCH OF BILATERAL LABIA MAJORA AND CLITORIS AND HYPERSENSITIVITY TO TOUCH AND PALPATION OF THE RIGHT ADDUCTOR MUSCLES. SHE WAS ALSO DIAGNOSED WITH OBTURATOR NEURALGIA, PUDENDAL NEURALGIA, COMPLEX REGIONAL PAIN SYNDROME II, SPONTANEOUS ORGASMS, DYSPAREUNIA, AND SPASTIC PELVIC FLOOR AS COMPLICATIONS FROM PREVIOUSLY IMPLANTED OBTRYX DEVICES WITH A PLAN OF CARE THAT INCLUDES THE FOLLOWING: REMOVAL OF GROIN MESH BILATERALLY (2 PIECES OF OBTRYX MESH IN EACH GROIN). REMOVAL OF VAGINAL SLING (1 COMPLETE OBTRYX, ONE PARTIALLY REMOVED). BILATREL PUDENDAL NERVE BLOCK. BOTOX INTO PELVIC FLOOR MUSCLES (400 UNITS). BULKAMED URETHRAL BULKING AGENT. HER REFRACTORY SYMPTOMS OF NEUROLOGICAL PAIN AND MYOFASCIAL PAIN INCLUDING GROIN PAIN WAS CAUSED IN PART BY THE OBTRYX SLING IMPLANTED ON (B)(6) 2018 UNTIL SOMETIME AFTER THE (B)(6) 2021 IMPLANTATION OF THE SECOND OBTRYX SLING. FOLLOWING THE IMPLANTATION OF THESE OBTRYX DEVICES, PLAINTIFF HAS BEEN DIAGNOSED WITH DEBILITATING PAIN, IMPAIRMENTS INCLUDING DIFFICULTY WALKING AND LOSS OF RECTAL CONTROL, GROIN PAIN, OBTURATOR AND PUDENDAL NEURALGIA, LOSS OF SEXUAL FUNCTION DUE TO SEVERE DYSPAREUNIA, SPONTANEOUS ORGASM, COMPLEX REGIONAL PAIN SYNDROME, SPASTIC PELVIC FLOOR SYNDROME, CHRONIC PELVIC PAIN, CHRONIC GROIN PAIN, AND OTHER COMPLICATIONS AND SYMPTOMS.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    873488 OBTRYX SYSTEM - HALO MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR OTN BOSTON SCIENTIFIC CORPORATION M0068505000 0021279324 08714729718987

    Patients

    Seq Age Sex Outcome Treatment
    1 Female Disability| R